AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2013
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
A Change of Heart?: Investigating the Effects of the 2011 FDA Warning
|
Sass, Jennifer | Work in Progress | Session 2 |
|
A Consumer-Led Intervention to Improve Pharmacists' Attitudes Toward Mental Illness: A Pilot Study
|
DaCosta, Alison | Work in Progress | Session 2 |
|
A Prospective Evaluation of an Inpatient Psychiatric Facility’s Ambulatory to Inpatient Medication Reconciliation Process: Discovering and Removing the Roadblocks to Success
|
Bowers, Jeff | Work in Progress | Session 1 |
|
A Quality Improvement Medication Utilization Evaluation for Appropriate and Safe Stimulant Use at a VA Hospital
|
Tanaka, Blissa | Work in Progress | Session 2 |
A Rasch Analysis of a Questionnaire Evaluating Patient-Reported Medication Attitudes and Knowledge in an Acute Inpatient Psychiatric Setting
|
Norman, Sarah | Original Research | Session 2 |
|
A Retrospective Analysis of Inpatient Utilization of Paliperidone Palmitate
|
Price, Paul | Encore Presentation | Session 2 |
|
A Retrospective Chart Review of a Symptom-Triggered Alcohol Withdrawal Protocol Versus Previous Standard of Care at a Veteran's Hospital
|
Zeier, Katy | Original Research | Session 1 |
|
Acute Effects of Olanzapine versus Haloperidol on Fasting Blood Glucose in the Medically Ill
|
Khorassani, Farah | Work in Progress | Session 2 |
|
Acute Intermittent Porphyria: A Case Report
|
Ware, Sloan | Therapeutic Case Report | Session 2 |
|
Adverse Childhood Experiences and Trust in the Medical Profession among Homeless Adolescents
|
Brahm, Nancy | Encore Presentation | Session 1 |
|
AEDs Reduce the Upper Photosensitivity Limit more than the Lower Photosensitivity Limit in photosensitive epilepsy patients: Implications for the design of the photosensitivity model
|
Reed, Ronald | Encore Presentation | Session 1 |
|
An Evaluation of Relapse with Regards to Dose and Concomitant Use of Sedating Medications in a Veteran Population Prescribed Buprenorphine/Naloxone: A Retrospective Cohort Study
|
Turner, Traci | Work in Progress | Session 2 |
|
ANCHOR-CD: The Abobotulinumtoxin-A Neurotoxin Clinical & Health Economics Outcomes Registry in Cervical Dystonia
|
Chen, Jack | Original Research | Session 1 |
|
Antidepressant Prescribing Patterns in Solid Tumor Cancers
|
Mulcahy, Kimberly | Work in Progress | Session 2 |
|
Antipsychotic Polypharmacy in Schizophrenia: patients, outcomes, and prescribing
|
Thedford, Sheryl | Work in Progress | Session 1 |
|
Antipsychotic Polypharmacy: An Evaluation of Appropriate Justification and Documentation
|
Price, Scott | Work in Progress | Session 2 |
|
Assessment of Adherence to Clozapine Titration Recommendations and Associated Effects on Blood Pressure
|
Adams, Katie | Work in Progress | Session 1 |
|
Assessment of the Utility of Clozapine Levels in Veterans at the Tuscaloosa VA Medical Center
|
Aviles-Gonzalez, Lizmarie | Work in Progress | Session 2 |
|
Association Between Clinician's Global Assessment of Functioning and Serum 25(OH) Vitamin D Levels in Adult Veterans with Schizophrenia Residing in a Long-term Care Facility
|
McGrane, Ian | Work in Progress | Session 1 |
|
Augmentation of clozapine with an additional antipsychotic in treatment resistant schizophrenia at the Louis Stokes Cleveland VAMC
|
Frilling, Lindsey | Work in Progress | Session 1 |
|
Awareness, Knowledge, and Use of Electronic Nicotine Delivery Systems in a Veteran Population
|
Price, Cristofer | Work in Progress | Session 2 |
|
Behavioral effects of extended-release memantine (28 mg, once daily) across a wide range of disease severity in patients with moderate to severe Alzheimer's disease: Post hoc analysis from a randomized trial
|
Tocco, Michael | Encore Presentation | Session 2 |
|
Cariprazine in the Treatment of Acute Mania in Bipolar Disorder: A Double-Blind, Placebo-Controlled, Phase III Trial
|
Ruth, Adam | Encore Presentation | Session 2 |
|
Chronic Amphetamine (AMPH) During Adolescent Rat Development Invokes Sterotypies and Disturbs Field Navigations when Stimulant Rechallenge Is Performed in Mature Rats
|
Willmore-Onuoha, Catherine | Original Research | Session 2 |
|
Clinical Pharmacy Specialist within a Memory Clinic
|
Moore, Lindsy | Innovative Practices | Session 1 |
|
Clinical Psychiatric Pharmacist Involvement in an Outpatient Buprenorphine Program
|
Grgas, Marina | Innovative Practices | Session 1 |
|
Clinical Relevance of Vilazodone Treatment in Patients with Major Depressive Disorder: Categorical Improvement in Symptoms
|
Trese, Anne Marie | Original Research | Session 1 |
Clozapine Augmentation: Inpatient Antipsychotic Selection and Likelihood of Continuation at Discharge
|
Leung, Jonathan | Original Research | Session 1 |
|
Clozapine Toxicity Requiring Intubation Associated with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
|
Leung, Jonathan | Therapeutic Case Report | Session 1 |
|
Collaborating Across the Country: Lessons Learned from a Multi-site, Pharmacy Resident Research Project
|
Jackson, Marie-Thérèse | Work in Progress | Session 2 |
|
Comparison of Continuation Electroconvulsive Therapy, Antidepressant Alone, and Combination Therapy for Treatment of Depression in the Veteran Population
|
Gray, Emily | Work in Progress | Session 2 |
|
Comparison of Symptom-Triggered vs. Fixed-schedule Dosing of Benzodiazepine to treat Ethanol Withdrawal Symptoms in an Inpatient Psychiatric Setting
|
Ouyang, Shuang | Work in Progress | Session 2 |
|
Comparison of two symptom-triggered alcohol withdrawal protocols: Severity Assessment Scale (SAS) and the Revised Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar)
|
Reiss, Rebecca | Work in Progress | Session 1 |
|
Continuation of Patient Assistance Program Benefits for Psychiatric Patients Receiving Psychotropic Medications: A Program Evaluation
|
Cobb, Carla | Original Research | Session 1 |
|
Conversion of Brand to Generic topiramate and lamotrigine
|
Schuh, Jennifer | Work in Progress | Session 2 |
|
Cost Effectiveness of Providing a 30 Day Supply of Medications on 30 Day Readmission Rates and Costs in an Uninsured Mental Health Population
|
Bhokasub, Darlene | Work in Progress | Session 2 |
|
Cost of Care Associated with Two Alternative Antidepressant Augmentation Therapies in the Treatment of Depression
|
Wade, Rolin | Original Research | Session 2 |
|
Decompensation After Clozapine Dose Reduction in Response to Serum Level Exceeding 1000ng/mL : A Case Report
|
Aviles-Gonzalez, Lizmarie | Therapeutic Case Report | Session 2 |
|
Design and Implementation of Acute Emergency Decision Making Aids for Case Managers: A Focus Group Study
|
Brahm, Nancy | Original Research | Session 1 |
|
Developing A Pharmacist-Run Vaccination Clinic at a Community Mental Health Center
|
Lorenz, Raymond | Innovative Practices | Session 2 |
|
Development of a Collaborative Drug Therapy Management Protocol for Extended-Release Intramuscular Naltrexone
|
Hebbard, Amy | Innovative Practices | Session 1 |
|
Dopill, an Electronic Pill Dispenser, Helping Evaluate and Control Medication Adherence in Patients with Schizophrenia
|
Vincent, Philippe | Encore Presentation | Session 1 |
|
Dronabinol for Emotion-Induced Reflex Epilepsy
|
Phelps, Nicole | Therapeutic Case Report | Session 1 |
|
Economic Impact of Public Benefit Changes on Seriously Mentally Ill Patients in Southern Arizona
|
Goldstone, Lisa | Original Research | Session 1 |
|
Effect of Valproate Dosing on Hospital Length of Stay in Acute Mania
|
Crouse, Ericka | Encore Presentation | Session 1 |
|
Effects of Alpha-1 Blockers on Sleep Apnea in Patients with Post Traumatic Stress Disorder-Induced Nightmares
|
Tran, Eric | Work in Progress | Session 1 |
|
Effects of Initiating Paliperidone Palmitate on Healthcare Resources in a Community Outpatient Psychiatric Clinic
|
Jeddi, Shabnam | Work in Progress | Session 2 |
|
Effects of Oral Caffeine on Seizure Duration in ECT
|
Magnuson, Tim | Work in Progress | Session 2 |
|
Efficacy and Clinical Relevance of Vilazodone in the Treatment of Major Depressive Disorder: A Pooled Analysis of Phase III Clinical Trials
|
Trese, Anne Marie | Encore Presentation | Session 1 |
|
Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: A Phase III, International, Randomized, Double-Blind, Placebo-Controlled Trial
|
Ruth, Adam | Encore Presentation | Session 2 |
|
Evaluating the Cost-Effectiveness of Administration of Long-Acting Injectable Antipsychotics in the Inpatient Setting
|
Price, Paul | Work in Progress | Session 2 |
|
Evaluating the Treatment of Borderline Personality Disorder in Light of Comorbid Psychiatric Conditions: Focus on Bipolar Disorder
|
Shuman, Michael | Work in Progress | Session 1 |
|
Evaluation of a Pharmacogenomics Education Tool for Psychiatric Patients
|
Vaith, Anna | Original Research | Session 1 |
|
Evaluation of Antipsychotic Polypharmacy Prescribing Practices in Outpatients at the Tuscaloosa Veterans Affairs Medical Center
|
Scheer, Corey | Work in Progress | Session 1 |
|
Evaluation of Antipsychotic Use in Children within Indiana Medicaid
|
Ho, Jessica | Encore Presentation | Session 1 |
|
Evaluation of Citalopram Prescribing Practices at the North Florida/South Georgia Veterans Health System: A Quality Improvement Project
|
Jones, Ashley Inez | Work in Progress | Session 2 |
|
Evaluation of Consumer and Provider Satisfaction with National Alliance on Mental Illness Written Medicine Information: A Multi-site, Collaborative Pharmacy Resident Project
|
Colvard, Michelle | Work in Progress | Session 1 |
|
Evaluation of Non-Psychiatric and Antipsychotic Medication Use in a Long-Term Inpatient Psychiatric Facility
|
Franck, Hugh | Original Research | Session 1 |
|
Evaluation of Outcomes in a Diabetes Education Group Utilizing Motivational Interviewing
|
Bremer, Anna | Work in Progress | Session 1 |
|
Evaluation of Patients on Aripiprazole, Ziprasidone or Olanzapine for Compliance with VA PBM Services Recommendations for Antipsychotic Selection in Schizophrenia and Schizoaffective Disorders and ADA Screening Guidelines for Antipsychotics
|
Clark, Jeffrey | Work in Progress | Session 1 |
|
Evaluation of QTc Prolongation and Dosage Effect with Citalopram
|
McClelland, Justine | Work in Progress | Session 2 |
|
Evaluation of the Effectiveness of a Pharmacist Driven Monitoring Database for Tardive Dyskinesia at a State Psychiatric Hospital
|
Diefenderfer, Lauren | Work in Progress | Session 1 |
|
Evaluation of Trazodone and Quetiapine for Insomnia in an Inpatient Psychiatric Setting
|
Doroudgar, Shadi | Work in Progress | Session 1 |
|
Examining the Clinical Outcomes of Inpatients Treated with Paliperidone Palmitate, a Long-acting Injectable Antipsychotic
|
Maroney, Megan | Work in Progress | Session 1 |
|
Expanding the CPNP Collegiate Chapter at Purdue University
|
Smith, Jenna | Innovative Practices | Session 2 |
|
Guanfacine Immediate Release vs. Guanfacine Extended Release: Comparative Medication Adherence, Resource Utilization, and Healthcare Costs Among Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Sikirica, Vanja | Original Research | Session 1 |
|
Healthcare Professionals’ Perceptions and Knowledge of Mental Illness and Terminology
|
Gonzalez, Misty | Work in Progress | Session 1 |
|
High Dose Haloperidol Decanoate Augmentation with Paliperidone Palmitate
|
Ross, Clint | Therapeutic Case Report | Session 1 |
|
Homeless Women's Impressions of How They are Perceived by Healthcare Providers and Their Resulting Unmet Healthcare Needs; The Impact Pharmacists Can Make
|
Rosenblatt, Holly | Work in Progress | Session 2 |
|
Hypertension in an Adolescent Secondary to Performance Enhancement Supplement Use
|
Brahm, Nancy | Therapeutic Case Report | Session 1 |
|
Impact of a Theophylline Loading Dose on Seizure Quality Indices During Electroconvulsive Therapy: A Retrospective Study
|
Kemp, Michael | Original Research | Session 1 |
|
Impact of clinical pharmacist services on hospital length of stay in an acute psychiatric unit
|
Tomko, John | Original Research | Session 1 |
|
Impact of Defining Polypharmacy and Notifying Providers When Criteria are Met
|
Ahlstrom, Danielle | Encore Presentation | Session 2 |
|
Impact of psychiatric pharmacist intervention in an aripiprazole cost avoidance project at VA Central Iowa Health Care System
|
Whipple, Sarah | Innovative Practices | Session 2 |
|
Implementing Pharmacogenomic Clinic for Treatment Refractory Depression
|
Leckband, Susan | Work in Progress | Session 1 |
|
Increasing Baseline Metabolic Monitoring for Patients Ordered Atypical Antipsychotics in an Acute Inpatient Setting
|
Butler, Phalyn | Work in Progress | Session 1 |
|
Influence of Smoking Status on Time to Discontinuation of Duloxetine in Patients with Major Depressive Disorder (MDD)
|
Palmer, Emma | Work in Progress | Session 2 |
|
Integration of Health Information Technology into a Pharmacotherapy Course Series: Use of an Academic Electronic Medical Record
|
Winans, Elizabeth | Encore Presentation | Session 1 |
|
Literature Review of Extrapyramidal Reation Reports with Selective Serotonin- and Serotonin Norepinephrine Reuptake Inhibitors: 1998 - 2012
|
Caley, Charles | Original Research | Session 2 |
|
Living with My Medication
|
Werremeyer, Amy | Original Research | Session 1 |
|
Lurasidone Adjunctive To Lithium Or Valproate For The Treatment Of Bipolar I Depression: Results Of A 6-Week, Double-Blind, Placebo-Controlled Study
|
Delgado, Liz | Encore Presentation | Session 1 |
|
Lurasidone Monotherapy For The Treatment Of Bipolar I Depression: Results Of A 6-Week, Double-Blind, Placebo-Controlled Study
|
Barber, Michael | Encore Presentation | Session 1 |
|
Medication and Education at Discharge: Pharmacist Assisted Care Transitions (MED PACT) To Reduce Psychiatric Hospital Readmissions
|
Montgomery, Jamie | Innovative Practices | Session 1 |
|
Medication Reconciliation Effectiveness in a Private Psychiatric Inpatient Hospital
|
Scholtes, Karin | Work in Progress | Session 1 |
|
Medication Therapy Services (MTS) and Assertive Community Treatment (ACT)
|
Gable, Kelly | Innovative Practices | Session 1 |
|
Memantine Hydrochloride to Assist With Opioid Rotation From Methadone
|
Denio, David | Work in Progress | Session 1 |
|
Metabolic Monitoring in Managed Care Pediatric Patients Who Received Second Generation Antipsychotics
|
Kauffman, Yardlee | Work in Progress | Session 1 |
|
Metabolic Monitoring of Atypical Antipsychotics within a Pharmacy Refill Service Program
|
Johnson, Dara | Work in Progress | Session 2 |
|
Methadone Toxicity: A Case Series and Review of the Literature with a Focus on Pharmacist Liability and Risk Management
|
Lyn, Aisheik | Original Research | Session 1 |
|
Multiple Medication Recommendations to Decrease Incidence of Falls in a Geriatric Inpatient Psychiatric Unit
|
Leach, Henry | Work in Progress | Session 2 |
|
Nonmedical Use of Prescription Stimulants: Cognitive Enhancement or Dissonance?
|
DiRaimo, Christopher | Original Research | Session 2 |
|
Outcomes Research in Young School Age Children with Autistic Disorder
|
Giannetti, Vincent | Work in Progress | Session 1 |
|
Paroxetine-Boosted Risperidone: A Case Report
|
McKee, Brian | Therapeutic Case Report | Session 2 |
|
Patient Satisfaction with Pharmacist Led Group Sessions in an Inpatient Acute Psychiatry Setting
|
Reinstatler, Kristina | Work in Progress | Session 2 |
|
Perceptions of Smoking Cessation from clients at an alcohol and other drug facility
|
Giannetti, Vincent | Work in Progress | Session 1 |
|
Performance on NCQA HEDIS Antidepressant Medication Management Measures in Patients Receiving Augmentation Therapy
|
Wade, Rolin | Original Research | Session 2 |
|
Pharmacist Interventions in a Psychiatric Primary Care Clinic
|
Wong, Kara | Innovative Practices | Session 1 |
|
Pharmacist Interventions in Long-Term Care
|
Brahm, Nancy | Original Research | Session 1 |
|
Pharmacist-Managed Olanzapine Long-Acting Injection Clinic in A Community Mental Health Center
|
Williams, Kelly | Innovative Practices | Session 1 |
|
Pharmacist-Physician Collaborative Care Model for Suboxone-Maintained Patients at a Health Department
|
DiPaula, Bethany | Innovative Practices | Session 1 |
|
Physician Consultation with Pharmacists and Adherence to Evidence-Based Medicine for Chronic Pain Management
|
Giannetti, Vincent | Work in Progress | Session 1 |
|
Pilot Surveillance Program for Antipsychotic-Induced Hypothermia in a Community-Based Treatment Program
|
Brahm, Nancy | Original Research | Session 1 |
|
Pisa Syndrome During Treatment with Quetiapine and Risperidone
|
Knox, Erin | Therapeutic Case Report | Session 1 |
|
Possible Interaction Between Combination of Clozapine and Mirtazapine
|
Goodrich, Andrea | Therapeutic Case Report | Session 1 |
|
Post-Traumatic Stress Disorder in Veterans of Operation Enduring Freedom/Operation Iraqi Freedom: Review of Treatment Compared to Evidence-Based Practice Guidelines
|
Moore, Troy | Work in Progress | Session 2 |
|
Prescribing Practices for Long-acting Injectable Antipsychotics in a Community Mental Health Center and the Utilization of Acute Care Services
|
Jones, Talia | Work in Progress | Session 2 |
|
Probable antipsychotic-mediated Neuroleptic Malignant Syndrome: a case report
|
Brahm, Nancy | Therapeutic Case Report | Session 1 |
|
Psychiatric Pharmacist in a Federally Qualified Health Center Primary Care Clinic
|
Bradley, Bridget | Innovative Practices | Session 2 |
|
Psychiatric Pharmacy Resident Services in USC Telehealth Therapy
|
Kawsky, Jaclyn | Innovative Practices | Session 1 |
|
Psychiatric Providers' Willingness to Participate in Shared Decision-making when Prescribing Psychotropic Medications
|
Ali, Saadia | Work in Progress | Session 1 |
|
Rates of hospitalization and emergency department visits in patients prescribed buprenorphine/naloxone in a Veterans Affairs (VA) healthcare system
|
Jackson, Marie-Thérèse | Work in Progress | Session 2 |
|
Rechallenge of Clozapine after Clozapine-induced Jaundice: a Case Report
|
Hall, Colleen | Therapeutic Case Report | Session 2 |
|
Relapse And Remission During 12 Months Of Double-Blind Treatment With Lurasidone Vs. Quetiapine Xr In Patients With Schizophrenia
|
Laird, Lyle | Encore Presentation | Session 1 |
|
Retrospective Analysis of Patients Receiving Long Acting Injectable Formulation Antipsychotics vs. Oral Formulation Antipsychotics: A Focus on ‘as needed’ Use Psychotropics with Regards to Adherence, efficacy, Safety and Costs.
|
Uhlyar, Stepan | Work in Progress | Session 1 |
|
Reversal of Korsakoff's Syndrome Following High Dose Intramuscular Thiamine
|
Brennan, Jessica | Therapeutic Case Report | Session 1 |
|
Review of Antipsychotic Use in VA-TVHS Community Living Centers
|
Salvig, Brent | Work in Progress | Session 1 |
|
Risk Factors Associated with Time-to-Readmission in Veterans with Schizophrenia or Schizoaffective Disorder at the VAWNY Healthcare System.
|
Utter, Brandon | Work in Progress | Session 1 |
|
Self-Reported Depression, Anxiety, Stress, and Related Coping Strategies among Pharmacy Students
|
Pfalzgraf, Andrea | Work in Progress | Session 1 |
|
Self-Reported Quality of Life, Treatment Effectiveness, Attitudes and Perceptions of Fibromyalgia Patients
|
Pfalzgraf, Andrea | Work in Progress | Session 1 |
|
Serotonin Transporter 5HTTLPR Polymorphism and Neurocognitive Outcomes in Lithium-Treated Pediatric and Adolescent Bipolar Disorder
|
Stevenson, James | Original Research | Session 1 |
|
Sustained Cognitive Improvement with Extended-Release Memantine (28 mg, Once Daily) in Moderate to Severe Alzheimer's Disease
|
Tocco, Michael | Encore Presentation | Session 2 |
|
Switching To Lurasidone In Patients With Schizophrenia: Tolerability And Effectiveness At 6 Weeks And 6 Months
|
Curtis, Judy | Encore Presentation | Session 1 |
|
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Therapeutic Uses
|
Chen, Jack | Original Research | Session 2 |
|
Testosterone Replacement in Male Patient with Treatment-resistant Depression and Hypogonadism
|
Harris, Suzanne | Therapeutic Case Report | Session 1 |
|
The Clinical Impact of an Antidepressant Pharmacogenomic Algorithm
|
Furmaga, Kevin | Encore Presentation | Session 1 |
|
The Effects of Discharge Counseling on Readmission Rate at an Inpatient Psychiatric Facility
|
Sweet, Ragan | Work in Progress | Session 1 |
|
The Financial Impact of Supportive Care vs Supportive Care Plus Buprenorphine/Naloxone for Inpatient Opiate Detoxification
|
Sullivan, Calleen | Work in Progress | Session 2 |
|
The Impact of Pharmacist Led Medication Counseling and Shared Decision Making in the Behavioral Health Inpatient Setting
|
Dugan, Rachel | Work in Progress | Session 2 |
|
The Student Pharmacists Chemical Health Scale-2013: High Risk Factors For Substance Use Disorders in Student Pharmacists
|
Norton, Merrill | Work in Progress | Session 2 |
|
Transitions Clinic Medication Education Group: A Pharmacist- Facilitated Component of an Intensive Outpatient Treatment Program
|
Frey, Theresa | Innovative Practices | Session 2 |
|
Treatment Compliance in OEF/OIF Veterans with PTSD Treated at the PTSD Medication Management Clinic at the VAWNY Healthcare System
|
Miller, Robert | Work in Progress | Session 1 |
|
Treatment of Antipsychotic-Induced Hyperprolactinemia with Bromocriptine: A Case Study
|
Brahm, Nancy | Therapeutic Case Report | Session 1 |
|
Type 3 Metabotropic Glutamate Receptor (GRM3) Variants are Associated with Spatial Working Memory and Symptom Changes after Antipsychotic Treatment
|
Bishop, Jeffrey | Encore Presentation | Session 1 |
|
Type of Antidepressant Medication Related to Adherence and Medication Costs in Patients with Diabetes and Comorbid Depression and/or Anxiety
|
Chavez, Benjamin | Original Research | Session 1 |
|
Understanding Consumer's Perceptions and Awareness of Psychiatric Pharmacists: A 6 year review of Surveys Conducted at the National Alliance on Mental Illness (NAMI) Annual Meeting
|
Moeller, Karen | Original Research | Session 2 |
|
Use of Antipsychotic Polypharmacy in a Pharmacist versus Psychiatrist Managed Outpatient Clinic
|
Cross, Bethany | Work in Progress | Session 1 |
|
Use of Buprenorphine/Naloxone for Opioid Dependency at a Veterans Affairs Drug Treatment Program.
|
Berger, Reisel | Work in Progress | Session 2 |